Report ID: GIR2110110005 | Category: Medical Care | Pages: 110 | Format: PDF | Published Date: November 19,2021
1 Market Overview
1.1 Product Overview and Scope of In Vivo and In Vitro ADME
1.2 Classification of In Vivo and In Vitro ADME by Type
1.2.1 Overview: Global In Vivo and In Vitro ADME Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global In Vivo and In Vitro ADME Revenue Market Share by Type in 2020
1.2.3 Small Molecules
1.2.4 Biologics
1.3 Global In Vivo and In Vitro ADME Market by End User
1.3.1 Overview: Global In Vivo and In Vitro ADME Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Global In Vivo and In Vitro ADME Market Size & Forecast
1.5 Global In Vivo and In Vitro ADME Market Size and Forecast by Region
1.5.1 Global In Vivo and In Vitro ADME Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global In Vivo and In Vitro ADME Market Size by Region, (2016-2021)
1.5.3 North America In Vivo and In Vitro ADME Market Size and Prospect (2016-2026)
1.5.4 Europe In Vivo and In Vitro ADME Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific In Vivo and In Vitro ADME Market Size and Prospect (2016-2026)
1.5.6 South America In Vivo and In Vitro ADME Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa In Vivo and In Vitro ADME Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 In Vivo and In Vitro ADME Market Drivers
1.6.2 In Vivo and In Vitro ADME Market Restraints
1.6.3 In Vivo and In Vitro ADME Trends Analysis
2 Company Profiles
2.1 Charles River
2.1.1 Charles River Details
2.1.2 Charles River Major Business
2.1.3 Charles River In Vivo and In Vitro ADME Product and Solutions
2.1.4 Charles River In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Charles River Recent Developments and Future Plans
2.2 Labcorp
2.2.1 Labcorp Details
2.2.2 Labcorp Major Business
2.2.3 Labcorp In Vivo and In Vitro ADME Product and Solutions
2.2.4 Labcorp In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Labcorp Recent Developments and Future Plans
2.3 ICON
2.3.1 ICON Details
2.3.2 ICON Major Business
2.3.3 ICON In Vivo and In Vitro ADME Product and Solutions
2.3.4 ICON In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ICON Recent Developments and Future Plans
2.4 Syneos Health
2.4.1 Syneos Health Details
2.4.2 Syneos Health Major Business
2.4.3 Syneos Health In Vivo and In Vitro ADME Product and Solutions
2.4.4 Syneos Health In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Syneos Health Recent Developments and Future Plans
2.5 Envigo
2.5.1 Envigo Details
2.5.2 Envigo Major Business
2.5.3 Envigo In Vivo and In Vitro ADME Product and Solutions
2.5.4 Envigo In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Envigo Recent Developments and Future Plans
2.6 Curia
2.6.1 Curia Details
2.6.2 Curia Major Business
2.6.3 Curia In Vivo and In Vitro ADME Product and Solutions
2.6.4 Curia In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Curia Recent Developments and Future Plans
2.7 Evotec
2.7.1 Evotec Details
2.7.2 Evotec Major Business
2.7.3 Evotec In Vivo and In Vitro ADME Product and Solutions
2.7.4 Evotec In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Evotec Recent Developments and Future Plans
2.8 Bioduro-Sundia
2.8.1 Bioduro-Sundia Details
2.8.2 Bioduro-Sundia Major Business
2.8.3 Bioduro-Sundia In Vivo and In Vitro ADME Product and Solutions
2.8.4 Bioduro-Sundia In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bioduro-Sundia Recent Developments and Future Plans
2.9 Lonza
2.9.1 Lonza Details
2.9.2 Lonza Major Business
2.9.3 Lonza In Vivo and In Vitro ADME Product and Solutions
2.9.4 Lonza In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Lonza Recent Developments and Future Plans
2.10 WuXi AppTec
2.10.1 WuXi AppTec Details
2.10.2 WuXi AppTec Major Business
2.10.3 WuXi AppTec In Vivo and In Vitro ADME Product and Solutions
2.10.4 WuXi AppTec In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 WuXi AppTec Recent Developments and Future Plans
2.11 IQVIA
2.11.1 IQVIA Details
2.11.2 IQVIA Major Business
2.11.3 IQVIA In Vivo and In Vitro ADME Product and Solutions
2.11.4 IQVIA In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 IQVIA Recent Developments and Future Plans
2.12 Tecan Group
2.12.1 Tecan Group Details
2.12.2 Tecan Group Major Business
2.12.3 Tecan Group In Vivo and In Vitro ADME Product and Solutions
2.12.4 Tecan Group In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Tecan Group Recent Developments and Future Plans
2.13 Pharmaron
2.13.1 Pharmaron Details
2.13.2 Pharmaron Major Business
2.13.3 Pharmaron In Vivo and In Vitro ADME Product and Solutions
2.13.4 Pharmaron In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Pharmaron Recent Developments and Future Plans
2.14 Shanghai Medicilon
2.14.1 Shanghai Medicilon Details
2.14.2 Shanghai Medicilon Major Business
2.14.3 Shanghai Medicilon In Vivo and In Vitro ADME Product and Solutions
2.14.4 Shanghai Medicilon In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Shanghai Medicilon Recent Developments and Future Plans
2.15 ChemPartner
2.15.1 ChemPartner Details
2.15.2 ChemPartner Major Business
2.15.3 ChemPartner In Vivo and In Vitro ADME Product and Solutions
2.15.4 ChemPartner In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 ChemPartner Recent Developments and Future Plans
2.16 Joinn Laboratories
2.16.1 Joinn Laboratories Details
2.16.2 Joinn Laboratories Major Business
2.16.3 Joinn Laboratories In Vivo and In Vitro ADME Product and Solutions
2.16.4 Joinn Laboratories In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Joinn Laboratories Recent Developments and Future Plans
2.17 RTI International
2.17.1 RTI International Details
2.17.2 RTI International Major Business
2.17.3 RTI International In Vivo and In Vitro ADME Product and Solutions
2.17.4 RTI International In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 RTI International Recent Developments and Future Plans
2.18 Eurofins Scientific
2.18.1 Eurofins Scientific Details
2.18.2 Eurofins Scientific Major Business
2.18.3 Eurofins Scientific In Vivo and In Vitro ADME Product and Solutions
2.18.4 Eurofins Scientific In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Eurofins Scientific Recent Developments and Future Plans
2.19 Aragen Life Sciences
2.19.1 Aragen Life Sciences Details
2.19.2 Aragen Life Sciences Major Business
2.19.3 Aragen Life Sciences In Vivo and In Vitro ADME Product and Solutions
2.19.4 Aragen Life Sciences In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Aragen Life Sciences Recent Developments and Future Plans
2.20 Sai Life Sciences
2.20.1 Sai Life Sciences Details
2.20.2 Sai Life Sciences Major Business
2.20.3 Sai Life Sciences In Vivo and In Vitro ADME Product and Solutions
2.20.4 Sai Life Sciences In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Sai Life Sciences Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global In Vivo and In Vitro ADME Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 In Vivo and In Vitro ADME Players Market Share
3.2.2 Top 10 In Vivo and In Vitro ADME Players Market Share
3.2.3 Market Competition Trend
3.3 In Vivo and In Vitro ADME Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global In Vivo and In Vitro ADME Revenue and Market Share by Type (2016-2021)
4.2 Global In Vivo and In Vitro ADME Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global In Vivo and In Vitro ADME Revenue Market Share by Application (2016-2021)
5.2 In Vivo and In Vitro ADME Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America In Vivo and In Vitro ADME Revenue by Type (2016-2026)
6.2 North America In Vivo and In Vitro ADME Revenue by Application (2016-2026)
6.3 North America In Vivo and In Vitro ADME Market Size by Country
6.3.1 North America In Vivo and In Vitro ADME Revenue by Country (2016-2026)
6.3.2 United States In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
6.3.3 Canada In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
6.3.4 Mexico In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe In Vivo and In Vitro ADME Revenue by Type (2016-2026)
7.2 Europe In Vivo and In Vitro ADME Revenue by Application (2016-2026)
7.3 Europe In Vivo and In Vitro ADME Market Size by Country
7.3.1 Europe In Vivo and In Vitro ADME Revenue by Country (2016-2026)
7.3.2 Germany In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
7.3.3 France In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
7.3.4 United Kingdom In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
7.3.5 Russia In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
7.3.6 Italy In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific In Vivo and In Vitro ADME Revenue by Type (2016-2026)
8.2 Asia-Pacific In Vivo and In Vitro ADME Revenue by Application (2016-2026)
8.3 Asia-Pacific In Vivo and In Vitro ADME Market Size by Region
8.3.1 Asia-Pacific In Vivo and In Vitro ADME Revenue by Region (2016-2026)
8.3.2 China In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
8.3.3 Japan In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
8.3.4 South Korea In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
8.3.5 India In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
8.3.7 Australia In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America In Vivo and In Vitro ADME Revenue by Type (2016-2026)
9.2 South America In Vivo and In Vitro ADME Revenue by Application (2016-2026)
9.3 South America In Vivo and In Vitro ADME Market Size by Country
9.3.1 South America In Vivo and In Vitro ADME Revenue by Country (2016-2026)
9.3.2 Brazil In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
9.3.3 Argentina In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa In Vivo and In Vitro ADME Revenue by Type (2016-2026)
10.2 Middle East & Africa In Vivo and In Vitro ADME Revenue by Application (2016-2026)
10.3 Middle East & Africa In Vivo and In Vitro ADME Market Size by Country
10.3.1 Middle East & Africa In Vivo and In Vitro ADME Revenue by Country (2016-2026)
10.3.2 Turkey In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
10.3.4 UAE In Vivo and In Vitro ADME Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
It contains all the geographic trends, and market analysis for global market